28th week of 2019 patent applcation highlights part 24 |
Patent application number | Title | Published |
20190211003 | NOVEL 16-MEMBER TRIAMILIDE DERIVATIVES AND USES THEREOF | 2019-07-11 |
20190211004 | PROCESS FOR PRODUCING LAMIVUDINE AND EMTRICITABINE | 2019-07-11 |
20190211005 | ARYL-2,2'-TANDEM BISTHIAZOLE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2019-07-11 |
20190211006 | AZTREONAM DERIVATIVES AND USES THEREOF | 2019-07-11 |
20190211007 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | 2019-07-11 |
20190211008 | SOLID STATE FORMS OF PALBOCICLIB DIMESYLATE | 2019-07-11 |
20190211009 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | 2019-07-11 |
20190211010 | PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 2019-07-11 |
20190211011 | COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES | 2019-07-11 |
20190211012 | Novel compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates | 2019-07-11 |
20190211013 | IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS | 2019-07-11 |
20190211014 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS | 2019-07-11 |
20190211015 | SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT | 2019-07-11 |
20190211016 | SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME | 2019-07-11 |
20190211017 | METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS | 2019-07-11 |
20190211018 | ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME | 2019-07-11 |
20190211019 | TRICYCLIC COMPOUNDS HAVING CYTOSTATIC AND/OR CYTOTOXIC ACTIVITY AND METHODS OF USE THEREOF | 2019-07-11 |
20190211020 | BICYCLIC HETEROARYL DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF | 2019-07-11 |
20190211021 | Preparation Method For Chiral Pyrrolopyrimidine Compound | 2019-07-11 |
20190211022 | CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND | 2019-07-11 |
20190211023 | IMIDAZOPYRIDINAMINE PHENYL DERIVATIVE AND USE THEREOF | 2019-07-11 |
20190211024 | SMALL MOLECULES HAVING ANTIVIRAL PROPERTIES | 2019-07-11 |
20190211025 | TRAF 6 INHIBITORS | 2019-07-11 |
20190211026 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | 2019-07-11 |
20190211027 | NIMBOLIDE ANALOGS AS ANTI-CANCER AGENTS AND PREPARATION THEREOF | 2019-07-11 |
20190211028 | METHODS FOR TREATMENT OF HEART FAILURE | 2019-07-11 |
20190211029 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | 2019-07-11 |
20190211030 | THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2019-07-11 |
20190211031 | PHOTOINITIATED REACTIONS | 2019-07-11 |
20190211032 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | 2019-07-11 |
20190211033 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | 2019-07-11 |
20190211034 | DITHIO ETP DERIVATIVES | 2019-07-11 |
20190211035 | N-Annulated Perylene Diimide Dimers with Active Pyrollic N-H Bonds | 2019-07-11 |
20190211036 | SPIRO BICYCLIC INHIBITORS OF MENIN-MLL INTERACTION | 2019-07-11 |
20190211037 | BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES IN ANTIMICROBIAL TREATMENT | 2019-07-11 |
20190211038 | BORON AND NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS | 2019-07-11 |
20190211039 | HYDROCARBYLOXYDISILANES | 2019-07-11 |
20190211040 | P-CHIRAL PHOSPHINE LIGANDS AND USE THEREOF FOR ASYMMETRIC SYNTHESIS | 2019-07-11 |
20190211041 | METHOD FOR PRODUCING HALOGEN-CROSSLINKED IRIDIUM DIMER | 2019-07-11 |
20190211042 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | 2019-07-11 |
20190211043 | COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF | 2019-07-11 |
20190211044 | Adjuvant Chemicals that Prevent Drug Tolerance and Persister Formation by Bacteria | 2019-07-11 |
20190211045 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | 2019-07-11 |
20190211046 | TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | 2019-07-11 |
20190211047 | ANTIFUNGAL COMPOUNDS | 2019-07-11 |
20190211048 | NUCLEOSIDE DERIVATIVE OR SALT THEREOF, POLYNUCLEOTIDE SYNTHESIS REAGENT, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE | 2019-07-11 |
20190211049 | ANTISENSE NUCLEIC ACIDS | 2019-07-11 |
20190211050 | ANTISENSE NUCLEIC ACIDS | 2019-07-11 |
20190211051 | FUNCTIONALIZED BILE ACIDS FOR THERAPEUTIC AND MATERIAL APPLICATIONS | 2019-07-11 |
20190211052 | METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | 2019-07-11 |
20190211053 | SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) REGIMEN | 2019-07-11 |
20190211054 | 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF | 2019-07-11 |
20190211055 | METHODS OF PURIFYING AND QUALIFYING ANTIBODIES | 2019-07-11 |
20190211056 | METHOD FOR PURIFYING PROTEIN USING ACTIVATED CARBON | 2019-07-11 |
20190211057 | TARGETED PRODRUG ENZYME FUSION CARRIER AND APPLICATION THEREOF | 2019-07-11 |
20190211058 | COMPOUNDS FOR PROTEASOME ENZYME INHIBITION | 2019-07-11 |
20190211059 | NOVEL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-07-11 |
20190211060 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | 2019-07-11 |
20190211061 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF THE PULMONARY FORM OF ALTITUDE SICKNESS CAUSED BY LACK OF OXYGEN AND REDUCED AIR PRESSURE | 2019-07-11 |
20190211062 | Modified Proteins and Methods of Use Thereof | 2019-07-11 |
20190211063 | PORE-FORMING PEPTIDES AND USES THEREOF | 2019-07-11 |
20190211064 | COMPLEXES OF CYTOMEGALOVIRUS PROTEINS | 2019-07-11 |
20190211065 | HIGH POTENCY IMMUNOGENIC COMPOSITIONS | 2019-07-11 |
20190211066 | VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS | 2019-07-11 |
20190211067 | MODIFIED MICROORGANISMS EXPRESSING SAGA AS ANTI-INFECTIVE AGENTS, PROBIOTICS AND FOOD COMPONENTS | 2019-07-11 |
20190211068 | Single-Domain Antibody Fusion Proteins with the Acid Tail of Alpha-Synuclein | 2019-07-11 |
20190211069 | Nucleic Acids for Single-Domain Antibodies with Thermal Stability Under Cytoplasmic Expression | 2019-07-11 |
20190211070 | TDP-43 MITOCHONDRIAL LOCALIZATION INHIBITOR FOR THE TREATMENT OF NEUROGENERATIVE DISEASE | 2019-07-11 |
20190211071 | PEPTIDES WITH VASODILATORY AND/OR DIURETIC FUNCTIONS | 2019-07-11 |
20190211072 | TRI-AGONIST FOR THE GLu, GLP-1 AND NPY2 RECEPTORS | 2019-07-11 |
20190211073 | SYNTHESIS METHOD FOR LIRAGLUTIDE WITH LOW RACEMATE IMPURITY | 2019-07-11 |
20190211074 | Methods for protein modification in pharmaceutical applications | 2019-07-11 |
20190211075 | ARTIFICIAL ANTIGEN PRESENTING CELLS FOR GENETIC ENGINEERING OF IMMUNE CELLS | 2019-07-11 |
20190211076 | TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF | 2019-07-11 |
20190211077 | IMPROVED FC-BINDING PROTEIN, METHOD FOR PRODUCING SAID PROTEIN, ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHOD FOR SEPARATING ANTIBODY USING SAID ADSORBENT | 2019-07-11 |
20190211078 | HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF MAKING THEREOF | 2019-07-11 |
20190211079 | ENGINEERED HETERODIMERIC PROTEIN DOMAINS | 2019-07-11 |
20190211080 | FERMENTATION PROCESS FOR ANTIBODY PRODUCTION | 2019-07-11 |
20190211081 | ANTIBODY CONSTANT REGION VARIANT | 2019-07-11 |
20190211082 | METHOD FOR PURIFYING ANTIBODY OR ANTIBODY FRAGMENT CONTAINING k-CHAIN VARIABLE REGION | 2019-07-11 |
20190211083 | HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES | 2019-07-11 |
20190211084 | ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF | 2019-07-11 |
20190211085 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | 2019-07-11 |
20190211086 | ANTI-TAU ANTIBODIES | 2019-07-11 |
20190211087 | CONFORMATION-INDEPENDENT ANTIBODIES AGAINST NEUROTOXIC TAU PROTEINS | 2019-07-11 |
20190211088 | POLYPEPTIDE TARGETING APTAMERS FOR CHARACTERIZATION, CAPTURE, AND CLINICAL MANAGEMENT OF CIRCULATING TUMOR CELLS | 2019-07-11 |
20190211089 | Activatable Binding Polypeptides and Methods of Identification and Use Thereof | 2019-07-11 |
20190211090 | METHOD OF TREATING OSTEOARTHRITIS WITH AN ANTIBODY TO NGF | 2019-07-11 |
20190211091 | Treatment of Ocular Diseases with Fully-Human Post-Translationally Modified Anti-VEGF Fab | 2019-07-11 |
20190211092 | ANTIBODIES AGAINST HMGB1, AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | 2019-07-11 |
20190211093 | HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS | 2019-07-11 |
20190211094 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATION OF SOLID MASSES COMPRISING POLYPEPTIDES AND/OR PROTEINS | 2019-07-11 |
20190211095 | THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | 2019-07-11 |
20190211096 | METHOD FOR PREPARING ANTI-AMH ANTIBODIES AND USES OF SAME | 2019-07-11 |
20190211097 | EFFECTOR-DEFICIENT ANTI-CD32A ANTIBODIES | 2019-07-11 |
20190211098 | USE OF PILRA BINDING AGENTS FOR TREATMENT OF A DISEASE | 2019-07-11 |
20190211099 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH SIGLEC-9 ACTIVITY MODULATORS | 2019-07-11 |
20190211100 | Human CD3 Binding Antibody | 2019-07-11 |
20190211101 | AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM | 2019-07-11 |
20190211102 | METHODS AND COMBINATION THERAPY TO TREAT CANCER | 2019-07-11 |